Monopar Therapeutics Inc (MNPR)
NASDAQ
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -333.4 | -37.428 | -40.881 | -41.726 | -48.691 | -62.248 | -81.684 |
Return on Equity (%) | -344.215 | -39.04 | -43.231 | -44.527 | -52.568 | -72.364 | -107.182 |
Return on Invested Capital (%) | -376.528 | -42.333 | -44.522 | -45.412 | -52.812 | -72.591 | -112.655 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 1.035 | 0.745 | 1.193 | 1.37 | 1.503 | 0.779 | 0.376 |
Earnings Per Share | -1.782 | -0.347 | -0.399 | -0.551 | -0.723 | -0.811 | -0.565 |
Cash Per Share | 0.967 | 0.742 | 1.248 | 1.461 | 1.612 | 0.632 | 0.489 |
Working Capital Per Share | 0.949 | 0.745 | 1.181 | 1.364 | 1.503 | 0.775 | 0.375 |
Operating Profit Per Share | N/A | N/A | N/A | 0.011 | N/A | N/A | N/A |
EBIT Per Share | -1.782 | -0.355 | -0.399 | -0.552 | -0.723 | -0.811 | -0.565 |
EBITDA Per Share | -1.782 | -0.355 | -0.399 | -0.552 | -0.723 | -0.811 | -0.565 |
Free Cash Flow Per Share | -1.782 | -0.347 | -0.399 | -0.551 | -0.723 | -0.811 | -0.565 |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 9.29M | 9.29M | 10.59M | 11.45M | 12.6M | 12.95M | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Shares Outstanding | 12.95M | N/A | N/A | 14.87M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 218.82M |
Price to Earnings Ratio | -26.04 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 30.12 |
Price to Book Ratio | 39.16 |
Dividend Yield | - |
Shares Outstanding | 5.28M |
Average Volume (1 week) | 74.86k |
Average Volume (1 Month) | 52.59k |
52 Week Change | 2,175.84% |
52 Week High | 41.94 |
52 Week Low | 1.545 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.